ALEXANDRIA, Va., July 9 -- United States Patent no. 12,352,767, issued on July 8, was assigned to University of Virginia Patent Foundation (Charlottesville, Va.).

"Method of treating cognitive decline associated with neurological diseases based on a decrease in FLT4 expression or activity" was invented by Jonathan Kipnis (Charlottesville, Va.) and Sandro Da Mesquita (Charlottesville, Va.).

According to the abstract* released by the U.S. Patent & Trademark Office: "In some embodiments herein, methods, compositions, and uses for countering the effects of aberrant meningeal lymphatic drainage and/or modulating lymphatic vessels of the central nervous system are described. In some embodiments, methods, compositions, or uses for treating, prev...